Harvard Bioscience (NASDAQ:HBIO) says that its wholly-owned subsidiary, Harvard Apparatus...

Harvard Bioscience (NASDAQ:HBIO) says that its wholly-owned subsidiary, Harvard Apparatus Regenerative Technology, has filed with the SEC for an IPO. Following the IPO, Harvard Apparatus Regenerative Technology will own HBIO's regenerative medicine device business, including devices to be used by physicians for growing organs outside the body for transplant. Summer Street Research Partners will act as sole book-running manager for the offering.